ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 9–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Sep 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
October 2025
Nuclear Technology
September 2025
Fusion Science and Technology
Latest News
A webinar, and a new opportunity to take ANS’s CNP Exam
Applications are now open for the fall 2025 testing period for the American Nuclear Society’s Certified Nuclear Professional (CNP) exam. Applications are being accepted through October 14, and only three testing sessions are offered per year, so it is important to apply soon. The test will be administered from November 12 through December 16. To check eligibility and schedule your exam, click here.
In addition, taking place tomorrow (September 19) from 12:00 noon to 1:00 p.m. (CDT), ANS will host a new webinar, “How to Become a Certified Nuclear Professional.” More information is available below in this article.
Florent Martinetti, Laurent Donadille, Sabine Delacroix, Catherine Nauraye, Aurélien De Oliveira, Joël Herault, Isabelle Clairand
Nuclear Technology | Volume 168 | Number 3 | December 2009 | Pages 721-727
Proton Therapy | Special Issue on the 11th International Conference on Radiation Shielding and the 15th Topical Meeting of the Radiation Protection and Shielding Division (PART 3) / Radiation Protection | doi.org/10.13182/NT09-A9296
Articles are hosted by Taylor and Francis Online.
A Monte Carlo modeling tool was applied at the Institut-Curie Centre de Protonthérapie d'Orsay, France, to simulate the passively scattered beam line used for treatment of ocular melanoma. The primary aim of this study is to validate the model for subsequent calculation of patient doses due to secondary neutrons.The Monte Carlo code MCNPX is used here to model the geometry of the beam line. The beam parameters at the entrance of the ophthalmologic beam line are not well known (beam emittance, lateral distribution, and energy spread). Hence, to accurately implement the beam source in the model, we need to calculate and measure these parameters in the first step of this study. Then, we perform comparisons between calculated and measured proton absorbed dose profiles under various scattering conditions.Comparisons between calculated and measured depth versus dose profiles show discrepancies <0.6 mm (range) and <1.1 mm (beam size and penumbra) for the lateral dose profiles. Hence, calculated relative dose profiles are considered to be correctly described by the Monte Carlo model. Some improvements are still needed to reproduce absolute dose profiles. This study should lead to the use of the numerical model for radiation protection applications.